How much insulin-like growth factor I (IGF-I) circulates? Impact of standardization on IGF-I assay accuracy

被引:55
作者
Quarmby, V
Quan, C
Ling, V
Compton, P
Canova-Davis, E
机构
[1] Genentech Inc, Dept Bioanalyt Technol, San Francisco, CA 94080 USA
[2] Genentech Inc, Dept Biostat, San Francisco, CA 94080 USA
[3] Genentech Inc, Dept Analyt Chem, San Francisco, CA 94080 USA
关键词
D O I
10.1210/jc.83.4.1211
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is a significant systematic difference between the normal range obtained from ethylenediamine tetraacetate plasma samples using the Genentech total insulin-like growth factor I (IGF-I) RIA and normal ranges for other total IGF-I RIAs. To determine whether the quality of the assay standard was the cause of this systematic difference, we analyzed commercially available preparations of recombinant human IGF-I (rhIGF-I) typical of those used as IGF-I immunoassay standards along with our own well characterized rhIGF-I assay standard. For the commercial standards, high performance liquid chromatography-derived purities were low, and some vendor-assigned protein concentrations were inconsistent with values from quantitative amino acid analysis. The Genentech rhIGF-I assay standard was highly pure and quantitatively correct. However, the poor quality of some commercial rhIGF-I preparations was not the primary reason for the systematic discrepancy between the Genentech total IGF-I RIA normal range and most other normal ranges. Most assays for total IGF-I are calibrated against the WHO International Reference Reagent (IRR) for IGF-I Immunoassays (87/ 518). The Genentech total IGF-I RIA is not calibrated against WHO IRR 87/518. The protein content assigned to WHO IRR 87/518 was a consensus value from a multicenter collaborative study. Physicochemical analyses showed that WHO IRR 87/518 is Met(-1)-IGF-I of low purity (44%), and that the assigned protein content is higher than the value determined by quantitative amino acid analysis. Thus, assays that are calibrated against WHO IRR 87/518 will report total IGF-I concentrations in excess of actual values. We believe that calibration against WHO IRR 87/518 is the cause of the systematic discrepancy between the Genentech IGF-I assay normal range and most other normal ranges, and that much of the plasma IGF-I concentration data in the literature are of questionable accuracy.
引用
收藏
页码:1211 / 1216
页数:6
相关论文
共 29 条
[11]   INSULIN-LIKE GROWTH-FACTORS AND THEIR BINDING-PROTEINS - BIOLOGICAL ACTIONS [J].
JONES, JI ;
CLEMMONS, DR .
ENDOCRINE REVIEWS, 1995, 16 (01) :3-34
[12]   THE RATIO BETWEEN SERUM LEVELS OF INSULIN-LIKE GROWTH-FACTOR (IGF)-I AND THE IGF BINDING-PROTEINS (IGFBP-1, IGFBP-2 AND IGFBP-3) DECREASES WITH AGE IN HEALTHY-ADULTS AND IS INCREASED IN ACROMEGALIC PATIENTS [J].
JUUL, A ;
MAIN, K ;
BLUM, WF ;
LINDHOLM, J ;
RANKE, MB ;
SKAKKEBAEK, NE .
CLINICAL ENDOCRINOLOGY, 1994, 41 (01) :85-93
[13]   SERUM INSULIN-LIKE GROWTH FACTOR-I IN 1030 HEALTHY-CHILDREN, ADOLESCENTS, AND ADULTS - RELATION TO AGE, SEX, STAGE OF PUBERTY, TESTICULAR SIZE, AND BODY-MASS INDEX [J].
JUUL, A ;
BANG, P ;
HERTEL, NT ;
MAIN, K ;
DALGAARD, P ;
JORGENSEN, K ;
MULLER, J ;
HALL, K ;
SKAKKEBAEK, NE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (03) :744-752
[14]   SEQUENCE-ANALYSIS OF SOMATOMEDIN-C - CONFIRMATION OF IDENTITY WITH INSULIN-LIKE GROWTH FACTOR-I [J].
KLAPPER, DG ;
SVOBODA, ME ;
VANWYK, JJ .
ENDOCRINOLOGY, 1983, 112 (06) :2215-2217
[15]   SERUM INSULIN-LIKE GROWTH-FACTOR-I IN A RANDOM-POPULATION SAMPLE OF MEN AND WOMEN - RELATION TO AGE, SEX, SMOKING-HABITS, COFFEE CONSUMPTION AND PHYSICAL-ACTIVITY, BLOOD-PRESSURE AND CONCENTRATIONS OF PLASMA-LIPIDS, FIBRINOGEN, PARATHYROID-HORMONE AND OSTEOCALCIN [J].
LANDINWILHELMSEN, K ;
WILHELMSEN, L ;
LAPPAS, G ;
ROSEN, T ;
LINDSTEDT, G ;
LUNDBERG, PA ;
BENGTSSON, BA .
CLINICAL ENDOCRINOLOGY, 1994, 41 (03) :351-357
[16]   ROLE OF THE INSULIN-LIKE GROWTH-FACTORS IN THE ENDOCRINE CONTROL OF GLUCOSE-HOMEOSTASIS [J].
LEWITT, MS .
DIABETES RESEARCH AND CLINICAL PRACTICE, 1994, 23 (01) :3-15
[17]   EFFECTS OF RECOMBINANT HUMAN INSULIN-LIKE GROWTH FACTOR-I (RHIGF-I) ON TOTAL AND FREE IGF-I CONCENTRATIONS, IGF-BINDING PROTEINS, AND GLYCEMIC RESPONSE IN HUMANS [J].
LIEBERMAN, SA ;
BUKAR, J ;
CHEN, SA ;
CELNIKER, AC ;
COMPTON, PG ;
COOK, J ;
ALBU, J ;
PERLMAN, AJ ;
HOFFMAN, AR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (01) :30-36
[18]  
LIEBERMAN SA, 1994, DIABETES, V45, P91
[19]   CHROMATOGRAPHIC DETERMINATION OF AMINO ACIDS BY THE USE OF AUTOMATIC RECORDING EQUIPMENT [J].
MOORE, S ;
STEIN, WH .
METHODS IN ENZYMOLOGY, 1963, 6 :819-831
[20]   Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes [J].
Moses, AC ;
Young, SCJ ;
Morrow, LA ;
OBrien, M ;
Clemmons, DR .
DIABETES, 1996, 45 (01) :91-100